| __timestamp | Bristol-Myers Squibb Company | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 12404000 |
| Thursday, January 1, 2015 | 5920000000 | 18343000 |
| Friday, January 1, 2016 | 4940000000 | 18108000 |
| Sunday, January 1, 2017 | 6411000000 | 17614000 |
| Monday, January 1, 2018 | 6345000000 | 35619000 |
| Tuesday, January 1, 2019 | 6148000000 | 58432000 |
| Wednesday, January 1, 2020 | 11143000000 | 63945000 |
| Friday, January 1, 2021 | 10195000000 | 72200000 |
| Saturday, January 1, 2022 | 9509000000 | 76642000 |
| Sunday, January 1, 2023 | 9299000000 | 57519000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals and biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Bristol-Myers Squibb Company and Evotec SE have demonstrated contrasting approaches to R&D investment.
Bristol-Myers Squibb, a giant in the pharmaceutical industry, has consistently invested heavily in R&D, with expenditures peaking in 2020 at over 11 billion dollars. This represents a staggering 145% increase from their 2014 spending. In contrast, Evotec SE, a smaller biotech firm, has shown a more modest growth in R&D spending, with a peak in 2022 at approximately 77 million dollars, marking a 518% increase since 2014.
This disparity highlights the different scales and strategies of these companies, with Bristol-Myers Squibb leveraging its vast resources to maintain a competitive edge, while Evotec SE focuses on strategic, targeted investments to drive innovation.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and argenx SE
Bristol-Myers Squibb Company or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Rhythm Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Genmab A/S and Evotec SE
Research and Development: Comparing Key Metrics for Insmed Incorporated and Evotec SE
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Evotec SE
Research and Development Investment: Perrigo Company plc vs Evotec SE
R&D Insights: How Iovance Biotherapeutics, Inc. and Evotec SE Allocate Funds
Amphastar Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending
R&D Insights: How BioCryst Pharmaceuticals, Inc. and Evotec SE Allocate Funds